Masimo Corporation
MASI
株式のランク
#2163
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
株価
$179.95
最終同期: 2026-06-12
時価総額
$9.42B
変化（1日）
0.00%
変化（1年）
21.32%
国
US
取引 Masimo Corporation (MASI)
カテゴリー
Healthcare
Masimo Corporation（MASI）の収益
Apr 2026 時点の収益 TTM: $1.56B
Masimo Corporation の最新の財務報告によると、現在の収益 (TTM) は $1.56B です。2023 年には $2.05B の収益があり、これは 2022 年の $2.04B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Masimo Corporation の収益履歴（2002 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.56B | -25.59% |
| 2024 | $2.09B | 2.26% |
| 2023 | $2.05B | 0.60% |
| 2022 | $2.04B | 64.28% |
| 2021 | $1.24B | 8.35% |
| 2020 | $1.14B | 21.95% |
| 2019 | $937.84M | 9.27% |
| 2018 | $858.29M | 8.61% |
| 2017 | $790.25M | 10.85% |
| 2016 | $712.90M | 13.14% |
| 2015 | $630.11M | 7.41% |
| 2014 | $586.64M | 7.20% |
| 2013 | $547.25M | 10.95% |
| 2012 | $493.23M | 12.36% |
| 2011 | $438.99M | 8.28% |
| 2010 | $405.41M | 16.12% |
| 2009 | $349.12M | 13.69% |
| 2008 | $307.07M | 19.82% |
| 2007 | $256.29M | 14.24% |
| 2006 | $224.34M | 107.93% |
| 2005 | $107.89M | 55.56% |
| 2004 | $69.36M | 48.41% |
| 2003 | $46.73M | 20.35% |
| 2002 | $38.83M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.59B | 2,889.09% |
US
|
|
| $35.48B | 2,176.80% |
IE
|
|
| $25.84B | 1,557.81% |
US
|
|
| $21.00B | 1,247.19% |
US
|
|
| - | - |
DE
|
